Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Store
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Estudios poblacionales de la relación entre el traumatismo craneoencefálico y la psiquiatría
$
0.00
Add to cart
Details
Michael E. Thase, MD: Editor’s Letter
$
0.00
Add to cart
Details
Ahmad Ghanizadeh, MD: Photophobia and Methylphenidate
$
30.00
Add to cart
Details
GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY: AUTHOR REPLY
$
0.00
Add to cart
Details
LETTER TO THE EDITOR: GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY
$
0.00
Add to cart
Details
Hypomania Induced by Escitalopram: 2 Case Reports
$
30.00
Add to cart
Details
Complete Resolution of Clozapine-Induced Sialorrhea with Low Dose Trihexyphenidyl
$
30.00
Add to cart
Details
Antidepressant Induced Apathy Responsive to Dose Reduction
$
30.00
Add to cart
Details
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder: A 12-week, Double-Blind, Placebo-Controlled Pilot Study
$
30.00
Add to cart
Details
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
$
30.00
Add to cart
Details
Patient Outcomes With Education, Drug Therapy, and Support: A Study of Venlafaxine ER-Treated Outpatients with Major Depressive Disorder
$
30.00
Add to cart
Details
Predictive Value of Early Improvement in Bipolar Depression Trials: A Post-hoc Pooled Analysis of Two 8-week Aripiprazole Studies
$
30.00
Add to cart
Details
The Effectiveness of Long-Acting Injectable Risperidone in a Population of Psychiatric Out-Patients: 1-Year Naturalistic Study
$
30.00
Add to cart
Details
Effectiveness of a Brain-Computer Interface Based Programme for the Treatment of ADHD: A Pilot Study
$
30.00
Add to cart
Details
The Effects of Psychotropic Medications on Human Sexuality
$
30.00
Add to cart
Details
Clinton D. Kilts, PhD: Imaging the Roles of the Amygdala in Drug Addiction
$
30.00
Add to cart
Details
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
$
30.00
Add to cart
Details
Gary M. Levin, PharmD: A Pharmacokinetic Drug-Drug Interaction Study of Venlafaxine and Indinavir
$
30.00
Add to cart
Details
Mark S. Bauer, MD: An Evidence-Based Review of Psychosocial Treatments for Bipolar Disorder
$
30.00
Add to cart
Details
Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine
$
30.00
Add to cart
Details
Paul J. Perry, PhD: Therapeutic Drug Monitoring of Antipsychotics
$
30.00
Add to cart
Details
Paul E. Keck, Jr., MD: Definition, Evaluation, and Management of Treatment Refractory Mania
$
30.00
Add to cart
Details
Jay D. Kranzler, MD, PhD: The Psychopharmacology of Fibromyalgia: A Drug Development Perspective
$
30.00
Add to cart
Details
Michael T. Compton, MD: Antipsychotic-Induced Hyperprolactinemia and Sexual Dysfunction
$
30.00
Add to cart
Details
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
$
30.00
Add to cart
Details
Consecuencias psicosociales de la depresión adolescente
$
0.00
Add to cart
Details
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
$
30.00
Add to cart
Details
Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective
$
30.00
Add to cart
Details
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: Overview of the Safety of Citalopram
$
30.00
Add to cart
Details
Laura Cousino Klein, PhD: Smoking Abstinence Impairs Time Estimation Accuracy in Cigarette Smokers
$
30.00
Add to cart
Details
Jane P. Gagliardi, MD: Evidence for the Treatment of Borderline Personality Disorder
$
30.00
Add to cart
Details
Nunzio Pomara, MD: Therapeutic Implications of HPA Axis Abnormalities in Alzheimer’s Disease: Review and Update
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
$
30.00
Add to cart
Details
Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?
$
30.00
Add to cart
Details
J. Douglas Bremner, MD: Functional Neuroanatomical Correlates of Traumatic Stress Revisited 7 Years Later, This Time with Data
$
30.00
Add to cart
Details
Naomi M. Simon, MD: Bupropion Sustained Release for Panic Disorder
$
30.00
Add to cart
Details
The Emergence of the Bipolar Spectrum: Validation along Clinical-Epidemiologic and Familial-Genetic Lines
$
30.00
Add to cart
Details
Cognitive Behavioral Approaches to the Treatment of Pain
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
$
30.00
Add to cart
Details
Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report
$
30.00
Add to cart
Details
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial
$
30.00
Add to cart
Details
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
$
30.00
Add to cart
Details
Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
$
30.00
Add to cart
Details
Pharmacology of Valproate
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
$
30.00
Add to cart
Details
Management of Late-Life Depression: Focus on Comorbid Conditions
$
30.00
Add to cart
Details
Ellen B. Dennehy, PhD: Concordance with Treatment Guidelines for Bipolar Disorder: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
New Developments in the Neurobiological Basis of Anxiety Disorders
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
$
30.00
Add to cart
Details
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
$
0.00
Add to cart
Details
Gender and Schizophrenia
$
0.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Previous
1
…
6
7
8
…
15
Next
Page load link
Go to Top
